摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-hydroxy-3-[3-(1-methylbenzimidazol-2-yl)phenyl]prop-2-enamide | 758693-28-6

中文名称
——
中文别名
——
英文名称
N-hydroxy-3-[3-(1-methylbenzimidazol-2-yl)phenyl]prop-2-enamide
英文别名
——
N-hydroxy-3-[3-(1-methylbenzimidazol-2-yl)phenyl]prop-2-enamide化学式
CAS
758693-28-6
化学式
C17H15N3O2
mdl
——
分子量
293.325
InChiKey
RWDIFWLNAIKKCY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    67.2
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    在 camphorsulfonic acid 作用下, 以 甲醇 为溶剂, 反应 1.0h, 生成 N-hydroxy-3-[3-(1-methylbenzimidazol-2-yl)phenyl]prop-2-enamide
    参考文献:
    名称:
    Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity
    摘要:
    A series of N-hydroxy-3-[3-(1-substituted-1H-benzoimidazol-2-yl)-phenyl]-acrylamides (5a-5ab) and N-hydroxy-3-[ 3-( 1,4,5-trisubstituted-1H-imidazol-2-yl)-phenyl]-acrylamides (12a-s) were designed, synthesized, and found to be nanomolar inhibitors of human histone deacetylases. Multiple compounds bearing an N1-piperidine demonstrate EC(50)s of 20-100 nM in human A549, HL60, and PC3 cells, in vitro and in vivo hyperacetylation of histones H3 and H4, and induction of p21(waf). Compound 5x displays efficacy in human tumor xenograft models. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.03.092
点击查看最新优质反应信息

文献信息

  • Histone deacetylase inhibitors
    申请人:Syrrx, Inc.
    公开号:US20040266769A1
    公开(公告)日:2004-12-30
    Compounds that may be used to inhibit histone deacetylase having the formula Z-Q-L-M or Z-L-M wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.
    可能用于抑制组蛋白去乙酰化酶的化合物具有以下公式:Z-Q-L-M或Z-L-M,其中M是一个能够与去乙酰化酶催化位点和/或属离子形成配合物的取代基;L是一个提供M取代基和化合物其余部分之间介于0-10个原子的取代基;Z和Q的定义如下。
  • HISTONE DEACETYLASE INHIBITORS
    申请人:Takeda San Diego, Inc.
    公开号:EP1608628A2
    公开(公告)日:2005-12-28
  • US7169801B2
    申请人:——
    公开号:US7169801B2
    公开(公告)日:2007-01-30
  • [EN] HISTONE DEACETYLASE INHIBITORS<br/>[FR] INHIBITEURS D'HISTONE DEACETYLASE
    申请人:SYRRX INC
    公开号:WO2004082638A2
    公开(公告)日:2004-09-30
    Compounds that may be used to inhibit histone deacetylase having the formula (I) or formula (II) wherein M is a substituent capable of complexing with a deacetylase catalytic site and/or a metal ion; L is a substituent providing between 0-10 atoms separation between the M substituent and the remainder of the compound; and Z and Q are as defined herein.
查看更多